BridgeMD
New treatment option for Concussion, Brain
Official title Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players
ClinicalTrials.gov ID: NCT05719844
What this study is testing
- What it's testing
- The goal of this study is to test the ability of a computerized neuropsychological battery to identify attentional disorders resulting from a concussion occurring during the practice of rugby. Thirty young people with a concussion (11-25 years old) will take several neuropsychological tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 11 to 25, men only. Healthy volunteers may be eligible.
You may be able to join if
- Patients :
- concussion in the context of the practice of rugby
- French or reading French without help
- Controls :
- no concussion
You likely can't join if
- Patients :
- Legal protection measure
- Other neurological or psychiatric pathologies prior to concussion episodes
- Diagnosis of a neurodevelopmental disorder in childhood
- Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
- Addictive behaviors
See the full eligibility criteria
- Patients :
- concussion in the context of the practice of rugby
- French or reading French without help
- Controls :
- no concussion
- practicing a non-contact sport (athletics, rowing, badminton, capoeira, circus, running, crossfit, cycling, dancing, climbing, fencing, fitness, golf, gymnastics, bodybuilding, swimming, skating, Qi Gong, Taï chi...
- age matched to patient (+/- 1 year)
- study level matched to patient (+/- 1 year)
- French or reading French without help
- Patients :
- Legal protection measure
- Other neurological or psychiatric pathologies prior to concussion episodes
- Diagnosis of a neurodevelopmental disorder in childhood
- Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
- Addictive behaviors
- Current major depressive disorder or treated with antidepressants or benzodiazepines for less than 3 months
- Severe visual or motor problems that may interfere with the performance of the tests
- Controls :
- Legal protection measure
- History of proven concussion
- Other neurological or psychiatric pathologies
- Diagnosis of a neurodevelopmental disorder in childhood
- Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
- Addictive behaviors
- Current major depressive episode or treated with antidepressants or benzodiazepines for less than 3 months
- Severe visual or motor problems that may interfere with the performance of the tests
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 11 years to 25 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.